Home DailyMed 3cb2d03c-6660-45d3-8ae2-59f0d71cbcf3 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 01:33:53
Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022314-001 EXFORGE HCT AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN EQ 5MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 N022314-002 EXFORGE HCT AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN EQ 5MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 N022314-003 EXFORGE HCT AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN EQ 10MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 N022314-004 EXFORGE HCT AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN EQ 10MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 N022314-005 EXFORGE HCT AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN EQ 10MG BASE;25MG;320MG TABLET / ORAL AB RLD, RS 2009-04-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 225 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N022314-001 EXFORGE HCT EQ 5MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N022314-002 EXFORGE HCT EQ 5MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N022314-003 EXFORGE HCT EQ 10MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N022314-004 EXFORGE HCT EQ 10MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N022314-005 EXFORGE HCT EQ 10MG BASE;25MG;320MG TABLET / ORAL AB RLD, RS 2009-04-30 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N022314-001 EXFORGE HCT EQ 5MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022314-002 EXFORGE HCT EQ 5MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022314-003 EXFORGE HCT EQ 10MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022314-004 EXFORGE HCT EQ 10MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022314-005 EXFORGE HCT EQ 10MG BASE;25MG;320MG TABLET / ORAL AB RLD, RS 2009-04-30 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022314-001 EXFORGE HCT EQ 5MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022314-002 EXFORGE HCT EQ 5MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022314-003 EXFORGE HCT EQ 10MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022314-004 EXFORGE HCT EQ 10MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022314-005 EXFORGE HCT EQ 10MG BASE;25MG;320MG TABLET / ORAL AB RLD, RS 2009-04-30 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022314-001 EXFORGE HCT EQ 5MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022314-002 EXFORGE HCT EQ 5MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022314-003 EXFORGE HCT EQ 10MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022314-004 EXFORGE HCT EQ 10MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022314-005 EXFORGE HCT EQ 10MG BASE;25MG;320MG TABLET / ORAL AB RLD, RS 2009-04-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022314-001 EXFORGE HCT EQ 5MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022314-002 EXFORGE HCT EQ 5MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022314-003 EXFORGE HCT EQ 10MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022314-004 EXFORGE HCT EQ 10MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022314-005 EXFORGE HCT EQ 10MG BASE;25MG;320MG TABLET / ORAL AB RLD, RS 2009-04-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022314-001 EXFORGE HCT EQ 5MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022314-002 EXFORGE HCT EQ 5MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022314-003 EXFORGE HCT EQ 10MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022314-004 EXFORGE HCT EQ 10MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022314-005 EXFORGE HCT EQ 10MG BASE;25MG;320MG TABLET / ORAL AB RLD, RS 2009-04-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022314-001 EXFORGE HCT EQ 5MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022314-002 EXFORGE HCT EQ 5MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022314-003 EXFORGE HCT EQ 10MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022314-004 EXFORGE HCT EQ 10MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022314-005 EXFORGE HCT EQ 10MG BASE;25MG;320MG TABLET / ORAL AB RLD, RS 2009-04-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022314-001 EXFORGE HCT EQ 5MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022314-002 EXFORGE HCT EQ 5MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022314-003 EXFORGE HCT EQ 10MG BASE;12.5MG;160MG TABLET / ORAL AB RLD 2009-04-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022314-004 EXFORGE HCT EQ 10MG BASE;25MG;160MG TABLET / ORAL AB RLD 2009-04-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022314-005 EXFORGE HCT EQ 10MG BASE;25MG;320MG TABLET / ORAL AB RLD, RS 2009-04-30 fd3edfee7708…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 6 · 225 observed states.
Observed Orange Book patent history# Patent history page 1 of 9 · 360 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-001 8101599 2023-05-16 Drug product 2012-01-30 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-001 8475839 2023-05-16 Drug product 2013-08-01 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-001 8475839*PED 2023-11-16 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-002 8101599 2023-05-16 Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-002 8475839 2023-05-16 Drug product 2013-08-01 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-002 8475839*PED 2023-11-16 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-003 8101599 2023-05-16 Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-003 8475839 2023-05-16 Drug product 2013-08-01 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-003 8475839*PED 2023-11-16 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-004 8101599 2023-05-16 Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-004 8475839 2023-05-16 Drug product 2013-08-01 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-004 8475839*PED 2023-11-16 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-005 8101599 2023-05-16 Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-005 8475839 2023-05-16 Drug product 2013-08-01 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022314-005 8475839*PED 2023-11-16 Pediatric extension 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022314-001 8101599 2023-05-16 Drug product 2012-01-30 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-001 8475839 2023-05-16 Drug product 2013-08-01 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-001 8475839*PED 2023-11-16 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-002 8101599 2023-05-16 Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-002 8475839 2023-05-16 Drug product 2013-08-01 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-002 8475839*PED 2023-11-16 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-003 8101599 2023-05-16 Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-003 8475839 2023-05-16 Drug product 2013-08-01 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-003 8475839*PED 2023-11-16 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-004 8101599 2023-05-16 Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-004 8475839 2023-05-16 Drug product 2013-08-01 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-004 8475839*PED 2023-11-16 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-005 8101599 2023-05-16 Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-005 8475839 2023-05-16 Drug product 2013-08-01 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022314-005 8475839*PED 2023-11-16 Pediatric extension 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022314-001 8101599 2023-05-16 Drug product 2012-01-30 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022314-001 8475839 2023-05-16 Drug product 2013-08-01 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022314-001 8475839*PED 2023-11-16 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022314-002 8101599 2023-05-16 Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022314-002 8475839 2023-05-16 Drug product 2013-08-01 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022314-002 8475839*PED 2023-11-16 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022314-003 8101599 2023-05-16 Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022314-003 8475839 2023-05-16 Drug product 2013-08-01 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022314-003 8475839*PED 2023-11-16 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022314-004 8101599 2023-05-16 Drug product 4b0b4de00fa7…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.